Clinical Trial Update: Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY) [NA]

View source ↗

Summary

A clinical trial called LOFTY is evaluating whether lobectomy-first or lymphadenectomy-first surgical strategies are preferable for operable non-small cell lung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non Small Cell Lung Cancer | NA | Status: RECRUITING